Kidney Stone Management Market - By Type (Calcium Oxalate, Calcium Phosphate, Uric Acid, Struvite, Cysteine), By Diagnostics (Abdominal X-ray, CT, Ultrasound, Abdominal MRI, Intravenous Pyelography), By Treatment - Global Forecast, 2023-2032
Published on: 2024-07-20 | No of Pages : 240 | Industry : Healthcare
Publisher : MIR | Format : PDF&Excel
Kidney Stone Management Market - By Type (Calcium Oxalate, Calcium Phosphate, Uric Acid, Struvite, Cysteine), By Diagnostics (Abdominal X-ray, CT, Ultrasound, Abdominal MRI, Intravenous Pyelography), By Treatment - Global Forecast, 2023-2032
Kidney Stone Management Market Size
Kidney Stone Management Market size was valued at USD 2.3 billion in 2022 and is estimated to reach USD 4.1 billion by 2032. Increasing prevalence and recurrence rate of kidney stones act as a major driving factor for kidney stones management industry growth over the anticipated timeframe. Factors such as dietary habits, dehydration, obesity, increased sodium intake, and others are contributing to kidney stones.
According to a recent study published in Science Direct, urolithiasis is one of the most common urologic diseases worldwide, with an estimated prevalence ranging from 1% to 13% in different regions across the globe. In the coming years, these statistics are anticipated to considerably increase kidney stones management demand.
Report Attribute | Details |
---|---|
Base Year | 2022 |
Kidney Stone Management Market Size in 2022 | USD 2.3 Billion |
Forecast Period | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR | 5.4% |
2032 Value Projection | USD 4.1 Billion |
Historical Data for | 2018 to 2022 |
No. of Pages | 193 |
Tables, Charts & Figures | 218 |
Segments covered | Type, Diagnostics, Treatment, and Region |
Growth Drivers |
|
Pitfalls & Challenges |
|
Kidney stone management refers to the medical and surgical approaches used to diagnose, treat, and prevent kidney stones, which are solid crystalline deposits that can form in the kidneys. Management of kidney stones typically includes various methods to alleviate symptoms, facilitate the passage or removal of stones, and develop strategies to prevent future stone formation.
COVID-19 Impact
The COVID-19 outbreak had a negative impact on the kidney stone management market revenue. The surging demand for COVID-19 treatment has impacted the adoption of kidney stone management procedures. The pandemic resulted in increased incidence and death rates from coronavirus, as people choose to avoid seeking other medical treatments in healthcare facilities. Many countries around the globe declared a national emergency and imposed a ban on all elective surgical procedures in both outpatient and inpatient settings. Such variables had impacted the growth of the kidney stones management market globally.
Kidney Stone Management Market Trends
Recent years have witnessed tremendous technological advances in ureteroscopy technique. The advent of flexible & semi-rigid ureteroscopy is one of the most significant advances that have revolutionized the treatment of intrarenal and proximal kidney stones.
- Flexible scopes are smaller in size offering an enhanced capacity to deflect as compared to rigid counterparts. This is accompanied with developed instrumentation in terms of addition of working channels, greater distal tip, active deflection and secondary deflection, and narrower shaft diameters. These advances have also expanded the use of techniques to treat other conditions such as urothelial carcinoma and ureteral strictures.
- The improvements in image quality due to use of high-definition medical camera and medical digital imaging systems has further led to better visualization and more accurate treatment. The most widely used laser lithotripters for stone fragmentation have also experienced remarkable advances such as smaller and more sophisticated equipment with high energy lasers.
- Other advancements in the field include introduction of improved accessories such as access sheaths and guidewires. Guidewires play an important role of navigating through an impacted calculus and protecting renal pelvis during ureteroscopy. These guidewires are now introduced in the form of hybrid guidewires that offer both flexibility of a hydrophilic wire at the tip and a stiff body to maintain rigidity.
Kidney Stone Management Market Analysis
The calcium oxalate segment was valued at USD 1,767.2 million in 2022 and is expected to grow at 5.5% CAGR by 2032. The kidney stones management market pre-dominantly consists of calcium oxalate.
- More than 75% of kidney stones are composed of calcium oxalate and calcium phosphate followed by struvite, uric acid and cysteine.
- Various risk factors that lead to calcium oxalate stone formation include diet that contains high levels of protein, oxalate, sodium or sugar. Other factors include obesity, various medical conditions and digestive disorders. Rising prevalence of obesity among population has led to an increased incidence of kidney stones, thereby, stimulating market growth.
Based on diagnostics, the kidney stone management market is categorised into abdominal x-ray, computed tomography, ultrasound, abdominal MRI, intravenous pyelography, and others. The ultrasound segment held a notable market share and is anticipated to reach USD 1,075.2 million by 2032. Ultrasound is widely used imaging modality for kidney stones diagnosis.
- This noninvasive procedure involves use of sound waves without need for radiation exposure and contrast dye. Hence, this technique is popular in pregnant women and patients who are allergic to contrast dye.
- As ultrasound does not employ ionizing radiation, American College of Radiology, American Urological Association, and European Association of Urology recommend it to be first-line diagnostic technology for young and pregnant patients.
- In addition, this technology can be used with increased accuracy in children due to their small body size. Ultrasound has good diagnostic ability as compared to CT scan for detection and sizing of small stones. As a result, the above-mentioned factors will stimulate market expansion.
The kidney stone management market from extracorporeal shock wave lithotripsy (ESWL) segment held a dominant market share in 2022 and is anticipated to reach USD 2,357 million by 2032. The dominant market share is attributed to convenience and non-invasive nature of shock waves procedure for treating kidney stones. These devices deliver shock waves externally through the skin, avoiding the need for invasive procedures.
- ESWL is generally less painful and comfortable for patients compared to surgical procedures. Anesthesia is often not required, and most patients can return to their regular activities shortly after treatment.
- Moreover, the ESWL devices are now being developed with new sources for generating shock waves, such as electromagnetic and piezoelectric sources. Additionally, these devices have been reduced in size occupying less space with more efficient targeting systems to deliver accurate energy to stones. As a result, the above-mentioned factors will stimulate market progress.
The U.S. dominated the North America kidney stones management market in 2022 and is anticipated to expand at a considerable pace to reach around USD 1.5 billion by 2032. The dominant market share is attributed to the increasing prevalence and recurrence rate of kidney stone disease in the country.
- U.S. witnesses high screening and diagnosis rate due to increased awareness regarding disease. Moreover, the presence of prominent players such as Boston Scientific Corporation, Becton, Dickinson and Company, and Olympus Corporation among others are engaged in the new product development & commercialization that facilitates the industrial expansion in the country.
- Additionally, better access to advanced treatment options such as ureteroscopy and minimally invasive surgeries, have made procedures safer, less invasive, and more effective. These advancements have attracted individuals who may have been hesitant about surgical options in the past. Thus, the above-mentioned variables would augment the business growth in the U.S.
Kidney Stone Management Market Share
The kidney stones management industry is consolidated in nature, with companies competing to offer superior kidney stones management in this business space. Prominent players such as Becton, Dickinson and Company, Boston Scientific Corporation, and Olympus Corporation hold a significant share in this market. These companies are diligently directing their efforts towards continuous type innovation to gain substantial market share.
Some of the eminent market participants operating in the kidney stones management industry include
- Allengers Medical Systems Ltd
- Boston Scientific Corporation
- Olympus Corporation
- Cook Medical LLC
- Coloplast A/S
- Karl Storz GmbH
- Richard Wolf GmbH
- Dornier MedTech
- EDAP TMS S.A
- Medispec Ltd
- DirexGroup
- Elmed Medical Systems
- Becton
- Dickinson and Company
- Siemens Healthineers
Kidney Stone Management Industry News
- In May 2021, Cook Medical announced that the Litho 150 laser from Quanta is now available in the U.S. Through its distribution channels. The system has indications for use in a variety of endoscopic and urological surgeries, including benign prostatic hyperplasia procedures and urological stone management. This product launch helped the company to enhance its customer base and gain advantage over its peers.
- In May 2020, EDAP TMS SA, announced that the company has signed an exclusive worldwide distribution agreement with Exact Imaging, a developer of high-resolution micro-ultrasound imaging technologies. Under the terms of the agreement, EDAP will market Exact Imaging’s micro-ultrasound diagnostic devices alongside its Focal One high intensity focused ultrasound (HIFU) treatment solution. This agreement helped the company to acquire complete end-to-end solution, from diagnosis through treatment, available in urology segment.
Kidney stones management market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Type, 2018-2032 (USD Million)
- Calcium oxalate
- Calcium phosphate
- Uric acid
- Struvite
- Cysteine
By Diagnostics, 2018-2032 (USD Million)
- Abdominal X-ray
- Computed tomography
- Ultrasound
- Abdominal MRI
- Intravenous pyelography
- Others
By Treatment, 2018-2032 (USD Million)
- Extracorporeal shock wave lithotripsy (ESWL)
- Ureteroscopy
- Percutaneous nephrolithotomy (PCNL)
- Others
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Rest of Middle East & Africa